Cargando…
The economic burden of individuals living with generalized myasthenia gravis and facing social determinants of health challenges
OBJECTIVE: Better understanding the impact of social determinants of health (SDOH) barriers from the patient perspective is crucial to improve holistic patient support in generalized myasthenia gravis (gMG), a rare autoimmune disorder with high disease and treatment burden. The objective of this stu...
Autores principales: | Hughes, Tom, Howard, James F., Silvestri, Nicholas J., Anderson, Ashley E. L., Sato, Mai, Suchotliff, Sharon, Guptill, Jeffrey T., Phillips, Glenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10520715/ https://www.ncbi.nlm.nih.gov/pubmed/37766748 http://dx.doi.org/10.3389/fpubh.2023.1247931 |
Ejemplares similares
-
Impact of social determinants of health on individuals living with generalized myasthenia gravis and implications for patient support programs
por: Hughes, Tom, et al.
Publicado: (2023) -
Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
por: Ignatova, Valentina, et al.
Publicado: (2022) -
Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy
por: Antonini, Giovanni, et al.
Publicado: (2023) -
Editorial: News and Views in the Management of Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2021) -
Antagonism of the Neonatal Fc Receptor as an Emerging Treatment for Myasthenia Gravis
por: Gable, Karissa L., et al.
Publicado: (2020)